Phase I Study of Pomalidomide, Bortezomib, and Dexamethasone (PVD) as First-Line Treatment of AL Amyloidosis or Light Chain Deposition Disease
Phase of Trial: Phase I
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Bortezomib (Primary) ; Pomalidomide (Primary) ; Dexamethasone
- Indications Amyloid light-chain amyloidosis; Kidney disorders
- Focus Adverse reactions
- 05 Apr 2017 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017.
- 05 Apr 2017 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017.
- 05 Apr 2017 Status changed from recruiting to suspended.